Diabetes disrupts circulation at nearly every level, from the largest arteries feeding your legs and heart down to capillaries so small that blood cells squeeze through single file. Persistently elevated blood sugar sets off a cascade of changes inside vessel walls, in the blood itself, and in the nerves that regulate blood flow, all of which conspire to reduce the delivery of oxygen and nutrients to tissues throughout the body. The damage is not limited to one organ or one type of vessel, which is why diabetes can simultaneously threaten your eyes, kidneys, feet, heart, and brain.
What High Blood Sugar Does to Blood Vessel Walls
Healthy blood vessels rely on a thin inner lining called the endothelium to stay relaxed and responsive. The endothelium produces nitric oxide, a signaling molecule that tells the surrounding muscle layer to loosen up, widening the vessel and letting blood pass freely. In diabetes, high glucose interferes with this process. Research shows that hyperglycemia disrupts the enzyme responsible for making nitric oxide through chemical modifications that effectively shut the enzyme down, reducing its output.1Cell Death & Disease. Vascular nitric oxide resistance in type 2 diabetes Without enough nitric oxide, vessels tend to stay constricted, blood pressure rises locally, and the inner lining becomes leaky and inflamed.
At the same time, high glucose ramps up the production of reactive oxygen species, which are aggressive molecules that damage cells. This oxidative stress further degrades nitric oxide before it can do its job and activates inflammatory pathways that make the vessel wall even more permeable.2Free Radical Biology and Medicine. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C High glucose also shifts the balance of hormone-like substances called prostanoids inside endothelial cells, tipping the scales toward constriction and clotting.3PubMed. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species
Over months and years, sugar molecules in the blood latch onto proteins in vessel walls and connective tissue, forming compounds called advanced glycation end products. These cross-link collagen fibers, making arteries stiff and less able to expand with each heartbeat. This stiffening happens during normal aging, but diabetes accelerates the process dramatically.4PubMed. Breakers of advanced glycation end products restore large artery properties in experimental diabetes The result is higher pulse pressures and more strain on the heart and on delicate downstream vessels.
Changes in the Blood Itself
Diabetes does not just damage the pipes; it changes what flows through them. Red blood cells in people with type 2 diabetes become stiffer and less able to deform, which matters because capillaries are often narrower than the cells themselves. Healthy red blood cells fold and flex to pass through; rigid ones create bottlenecks. This reduced deformability, combined with increased red cell clumping, raises the viscosity of whole blood, making it harder to push through the smallest vessels.5Biophysical Journal. Modeling of Biomechanics and Biorheology of Red Blood Cells in Type 2 Diabetes Mellitus6PubMed Central. Hemorheological disorders in diabetes mellitus
On top of thicker blood, diabetes tilts the clotting system toward forming clots that are harder to dissolve. Platelets become overly reactive and tend to stick together more readily, while the body’s clot-dissolving machinery is suppressed. The net effect is a prothrombotic state: clots form more easily and break down more slowly, raising the risk of blockages in arteries already narrowed by stiffening and plaque.7PubMed Central. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
Peripheral Artery Disease and the Legs
The legs are one of the first places people notice circulatory trouble, often as cramping pain when walking that eases with rest. This symptom, called intermittent claudication, signals that the arteries feeding the leg muscles cannot deliver enough blood during exercise. Peripheral artery disease is far more common in people with diabetes: hospital-based studies report that it is two to seven times more prevalent than in the general population, with rates ranging from about 9% to 55% depending on the population studied and the method used to diagnose it.8PubMed Central. Diabetes and peripheral artery disease: A review A systematic review comparing diabetic and non-diabetic groups found rates of roughly 20% to 50% in those with diabetes versus 10% to 26% in those without.8PubMed Central. Diabetes and peripheral artery disease: A review
What makes peripheral artery disease in diabetes particularly tricky is that neuropathy can mask the usual warning signs. If you have lost sensation in your feet and calves, you may not feel the cramping that would normally send you to a doctor, so the disease can progress silently until a wound refuses to heal or an ulcer appears.
Microvascular Disease in the Eyes and Kidneys
Diabetes draws a distinction between macrovascular disease (the larger arteries) and microvascular disease (the tiny capillaries and arterioles). The eyes and kidneys are two of the most vulnerable targets for small-vessel damage.
In the retina, high blood sugar injures the cells that wrap around and support capillaries, called pericytes. As pericytes die off, capillary walls weaken and small balloon-like bulges form. Researchers have mapped the sequence: local oxygen deprivation triggers a growth signal that kills pericytes, and the resulting fragile vessel segments attract inflammatory white blood cells that compound the damage.9Diabetes. Differentiating Microaneurysm Pathophysiology in Diabetic Retinopathy Through Objective Analysis of Capillary Nonperfusion, Inflammation, and Pericytes Left unchecked, these changes progress to diabetic retinopathy, the leading cause of vision loss in working-age adults.
In the kidneys, the story begins with hyperfiltration. Early in diabetes, the tiny filtration units work harder than they should, processing blood at an elevated rate that is observed in a substantial proportion of patients with both type 1 and type 2 diabetes.10PubMed Central. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment This overwork is driven by increased pressure inside the glomerulus, the kidney’s filtration cluster, which forces more fluid and protein through the capillary walls than normal. Over time, the membranes thicken, scarring sets in, and filtration capacity drops. The progression from hyperfiltration to kidney failure can span decades, but high blood sugar and high blood pressure both speed it up.
What connects these seemingly different organs is a shared process at the capillary level: thickening of the basement membrane, accumulation of advanced glycation end products, oxidative stress, and chronic low-grade inflammation.11PubMed Central. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? These same changes also feed into the larger arteries’ disease, which is why people with microvascular complications frequently develop macrovascular ones as well.
How Poor Circulation Damages Nerves
Peripheral nerves have their own tiny blood supply, and diabetes chokes it. The blood vessels feeding nerves develop the same endothelial dysfunction seen everywhere else in the body: reduced nitric oxide, increased constriction, and impaired flow. Animal studies have shown that diabetes causes a specific deficit in the ability of these nerve-feeding vessels to relax, making them overly sensitive to constrictors and likely to restrict blood delivery.12PubMed. Effects of diabetes on reactivity of sciatic vasa nervorum in rats
The consequences go beyond numbness. When nerve fibers lose their blood supply, they die off in patches, and researchers have proposed that the accumulation of these focal losses is what produces the characteristic pattern of diabetic neuropathy: symptoms that start at the tips of the longest nerves (the toes) and creep upward.13PubMed Central. Mechanism of diabetic neuropathy: Where are we now and where to go? The damage also slows nerve regeneration, because the impaired blood supply creates a hostile environment for regrowth even after an injury.14Diabetes. Influence of Experimental Diabetes on the Microcirculation of Injured Peripheral Nerve: Functional and Morphological Aspects
The Diabetic Foot and Wound Healing
The feet sit at the intersection of every circulatory problem diabetes causes. Reduced large-vessel flow from peripheral artery disease means less blood reaches the foot overall. Microvascular damage impairs the capillary exchange that delivers oxygen to skin and muscle. Neuropathy destroys protective sensation, so small injuries go unnoticed. And autonomic nerve damage disrupts blood-flow regulation in the foot, diverting blood through shunts that bypass the capillary beds where exchange actually happens.15PubMed. Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot The paradox is that the foot may feel warm to the touch because blood is flowing through it, but it is flowing through the wrong pathways and never reaching the tissue that needs it.
When a wound does occur, the impaired perfusion and blunted immune response slow healing to a crawl. A review of diabetic foot ulcers describes this as a convergence of neuropathy, vascular insufficiency, and weakened immune defenses, all working together to keep wounds open and vulnerable to infection.16PubMed Central. A comprehensive review on diabetic foot ulcer addressing vascular insufficiency, impaired immune response, and delayed wound healing mechanisms Diabetic foot ulcers remain one of the leading reasons for non-traumatic lower-limb amputations worldwide.
Circulation in the Heart and Brain
The heart’s own blood supply is not spared. Even when the large coronary arteries look clear on an angiogram, people with diabetes can have dysfunction in the coronary microcirculation, the network of tiny vessels that fine-tunes blood delivery to match the heart muscle’s moment-to-moment demands. When this regulation breaks down, parts of the heart may not get enough oxygen during exertion or stress, contributing to chest pain and heart failure even without a classic blockage.17PubMed Central. Coronary microvascular dysfunction in diabetes mellitus
In the brain, diabetes impairs the autoregulatory system that keeps cerebral blood flow steady despite changes in blood pressure. Healthy brain vessels constrict or dilate automatically to maintain a consistent supply; in type 2 diabetes, this capacity is diminished even before obvious complications appear.18Clinical Science. Dynamic cerebral autoregulatory capacity is affected early in Type 2 diabetes When autoregulation fails, the brain becomes more vulnerable to blood-pressure swings, increasing the risk of small strokes and tiny areas of tissue death. Microvascular dysfunction has been linked to a higher risk of lacunar strokes and deep brain hemorrhages.19PubMed Central. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression There is also growing interest in whether this same process, through repeated microinfarctions and neuronal loss, contributes to the higher rates of cognitive decline and dementia seen in people with diabetes.20PubMed Central. Impaired Cerebral Autoregulation-A Common Neurovascular Pathway in Diabetes may Play a Critical Role in Diabetes-Related Alzheimer’s Disease
Metabolic Memory and Why Early Control Matters
One of the more sobering findings in diabetes research is the concept of metabolic memory. Even temporary periods of high blood sugar can leave lasting marks on blood vessels through persistent changes in gene activity. These epigenetic alterations mean that the endothelial cells “remember” the high-glucose exposure and continue behaving as though sugar levels are still elevated, sustaining inflammation and dysfunction long after blood sugar normalizes.21PubMed Central. Metabolic memory: mechanisms and diseases
This has real clinical implications. The landmark UKPDS trial followed people with type 2 diabetes for ten years after the main study ended and found that those who had been in the intensive glucose-control group still showed benefits a decade later, including a 24% reduction in microvascular disease and a 15% reduction in heart attacks, even though blood sugar levels in the two groups had converged by that point.22PubMed. 10-year follow-up of intensive glucose control in type 2 diabetes The flip side of metabolic memory is that delaying good control can lock in damage that persists even if you get things under control later.
What Tighter Glucose Control Actually Achieves
Bringing blood sugar closer to normal reduces the risk of microvascular complications more clearly than it reduces macrovascular ones. A meta-analysis of trials comparing intensive versus standard glucose-lowering found that intensive therapy cut the risk of retinopathy by about 15%, nephropathy by roughly 29%, and composite microvascular outcomes by about 12%.23PubMed. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes The picture for heart attacks and strokes was more mixed: non-fatal heart attacks dropped, but the overall composite of major cardiovascular events did not change significantly.23PubMed. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes A separate pooled analysis found that kidney events dropped by about 20% and eye events by about 13% with more intensive control, though nerve complications did not budge.24PubMed Central. Intensive glucose control and macrovascular outcomes in type 2 diabetes / Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes – Section: Results
The practical takeaway is that glucose control is necessary but not sufficient. It protects the smallest vessels most reliably. For the larger vessels and the heart, blood pressure management, cholesterol treatment, and other interventions carry at least as much weight.
Exercise and Newer Medications
Exercise directly improves microvascular function in type 2 diabetes. Training programs, whether endurance, interval, or resistance based, have been shown to improve the ability of small vessels in skeletal muscle to dilate, enhance insulin signaling in those vessels, and reduce capillary loss.25PubMed Central. Endurance, interval sprint, and resistance exercise training: impact on microvascular dysfunction in type 2 diabetes This is separate from the blood-sugar-lowering effect of exercise; it appears to restore some of the endothelial function that diabetes strips away.
Among medications, newer drug classes have shown vascular benefits beyond glucose reduction. A study comparing GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination to insulin found that all three newer regimens improved markers of arterial stiffness and endothelial health more than insulin did, despite achieving the same degree of blood sugar control.26PubMed Central. Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment This suggests that some of the vascular damage in diabetes is driven by mechanisms that these drugs address independently of their sugar-lowering effect.
Why Standard Screening Can Miss the Problem
The ankle-brachial index, or ABI, is the most common bedside test for peripheral artery disease. It compares blood pressure at the ankle with blood pressure in the arm. In the general population it works well, but in diabetes it has a blind spot. A study of nearly 100 people with diabetes found that while a positive ABI result was almost always correct (specificity around 98%), the test missed roughly two-thirds of confirmed cases, with a sensitivity of only about 35%.27PubMed Central. Accuracy of ankle-brachial index in screening for peripheral arterial disease in people with diabetes The reason is that diabetes-related arterial calcification can make the vessels at the ankle incompressible, producing a falsely normal or even elevated reading despite significant narrowing upstream. If you have diabetes and a normal ABI result but symptoms that suggest reduced blood flow, additional imaging is worth pursuing.
Sex Differences in Diabetic Vascular Risk
Before menopause, women generally enjoy a lower rate of cardiovascular disease than men, an advantage often attributed to hormonal factors and more favorable lipid profiles. Diabetes erases that gap. Research shows that premenopausal women with type 2 diabetes have lipid profiles comparable to or worse than those of age-matched men with the same condition, effectively abolishing the cardiovascular protection that women typically carry into midlife.28PubMed Central. Diabetic Cardiovascular Complications in Women and Young Adults This means that a 40-year-old woman with poorly controlled diabetes may face vascular risks similar to those of a male peer, a fact that both patients and clinicians sometimes underestimate. The reasons are not fully understood, but the loss of favorable lipid and lipoprotein patterns is one clear contributor.